Prof. Dr. Semra Demokan is Professor of Basic Oncology at the Oncology Institute, Istanbul University, Türkiye. She received her B.Sc. in Molecular Biology and Genetics from Boğaziçi University and her M.Sc. and Ph.D. in Basic Oncology, Oncological Biology and Immunology from Oncology Institute, Istanbul University. From 2007 to 2009, she completed a Research Fellowship in the Department of Otolaryngology–Head and Neck Surgery at Johns Hopkins University School of Medicine (Baltimore, USA), where she conducted translational research in head and neck cancer biology and epigenetics. Prof. Demokan leads multidisciplinary research integrating experimental cancer biology, molecular diagnostics, bioinformatics, and translational oncology. She has served as principal investigator and collaborator in nationally funded projects and has published extensively in cancer epigenetics, molecular biomarkers, and precision oncology. Her research focuses on cancer genomics, epigenetics, multi-omics, and molecular diagnostics for biomarker discovery and therapeutic target identification. Her interests include DNA methylation, liquid biopsy, tumor microbiome, extracellular vesicles, organelle biology, therapeutic resistance, and personalized cancer medicine, particularly in head and neck and pancreatic cancers. She aims to translate molecular discoveries into clinical applications and serves as Guest Editor and reviewer for international scientific journals.